Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and 32 heterozygote HIV-1-infected patient was not associated with functional cure | Zendy

Ruxandra Câlin | Zendy; S. Fourati | Zendy; Lars Schneider | Zendy; Agnès GautheretDejean | Zendy; Sidonie Lambert-Niclot | Zendy; Marc Wirden | Zendy; G. Carcelain | Zendy; Christine Katlama | Zendy; AnneGeneviève Marcelin | Zendy; Roland Tubiana | Zendy

Open Access

Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and 32 heterozygote HIV-1-infected patient was not associated with functional cure

Author(s) -

Ruxandra Câlin,

S. Fourati,

Lars Schneider,

Agnès GautheretDejean,

Sidonie Lambert-Niclot,

Marc Wirden,

G. Carcelain,

Christine Katlama,

AnneGeneviève Marcelin,

Roland Tubiana

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - French

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku370

Subject(s) - human immunodeficiency virus (hiv) , antibody , virology , heterozygote advantage , human leukocyte antigen , immunology , rna , medicine , dna , biology , allele , genetics , antigen , gene

Sorbonne Universités, UPMC Paris 06, Paris F-75013, France; INSERM-UMR_S 943 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France; AP-HP, GH Pitié Salpêtrière, Maladies Infectieuses, Paris F-75013, France; INSERM-UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France; AP-HP, GH Pitié Salpêtrière, Laboratoire de Virologie, Paris F-75013, France; AP-HP, GH Pitié Salpêtrière, Laboratoire d’Immunologie, Paris F-75013, France; INSERM, U1135, Centre d’Immunologie et des Maladies Infectieuses, Paris F-75013, France

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research